BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND STK11, LKB1, 6794, ENSG00000118046, Q15831, PJS
43 results:

  • 1. [Cytopathological characteristics of SMARCA4-deficient thoracic undifferentiated tumors in serous effusion].
    Wang WN; Liu XT; Liang YM
    Zhonghua Bing Li Xue Za Zhi; 2024 Feb; 53(2):143-148. PubMed ID: 38281781
    [No Abstract]    [Full Text] [Related]  

  • 2. Comparative bioinformatic analysis of KRAS, stk11 and KEAP1 (co-)mutations in non-small cell lung cancer with a special focus on KRAS G12C.
    Boeschen M; Kuhn CK; Wirtz H; Seyfarth HJ; Frille A; Lordick F; Hacker UT; Obeck U; Stiller M; Bläker H; von Laffert M
    Lung Cancer; 2023 Oct; 184():107361. PubMed ID: 37699269
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Celastrol as an emerging anticancer agent: Current status, challenges and therapeutic strategies.
    Wang C; Dai S; Zhao X; Zhang Y; Gong L; Fu K; Ma C; Peng C; Li Y
    Biomed Pharmacother; 2023 Jul; 163():114882. PubMed ID: 37196541
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Molecular markers of metastatic disease in KRAS-mutant lung adenocarcinoma.
    Boiarsky D; Lydon CA; Chambers ES; Sholl LM; Nishino M; Skoulidis F; Heymach JV; Luo J; Awad MA; Janne PA; Van Allen EM; Barbie DA; Vokes NI
    Ann Oncol; 2023 Jul; 34(7):589-604. PubMed ID: 37121400
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The liver kinase B1 supports mammary epithelial morphogenesis by inhibiting critical factors that mediate epithelial-mesenchymal transition.
    Tzavlaki K; Ohata Y; Morén A; Watanabe Y; Eriksson J; Tsuchiya M; Kubo Y; Yamamoto K; Sellin ME; Kato M; Caja L; Heldin CH; Moustakas A
    J Cell Physiol; 2023 Apr; 238(4):790-812. PubMed ID: 36791282
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Efficacy of aromatase inhibitor therapy in a case with large cell calcifying Sertoli cell tumour-associated prepubertal gynaecomastia.
    Kağızmanlı GA; Besci Ö; Acinikli KY; Şeker G; Yaşar E; Öztürk Y; Demir K; Böber E; Abacı A
    J Pediatr Endocrinol Metab; 2022 Dec; 35(12):1565-1570. PubMed ID: 36181314
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. bone morphogenetic protein inhibitors and mitochondria targeting agents synergistically induce apoptosis-inducing factor (AIF) caspase-independent cell death in lung cancer cells.
    Mondal A; Roberge J; Gilleran J; Peng Y; Jia D; Akel M; Patel Y; Zoltowski H; Doraiswamy A; Langenfeld J
    Cell Commun Signal; 2022 Jun; 20(1):99. PubMed ID: 35761398
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Genetic Connections and Convergent Evolution of Tropical Indigenous Peoples in Asia.
    Deng L; Pan Y; Wang Y; Chen H; Yuan K; Chen S; Lu D; Lu Y; Mokhtar SS; Rahman TA; Hoh BP; Xu S
    Mol Biol Evol; 2022 Feb; 39(2):. PubMed ID: 34940850
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Nuts and bolts of the salt-inducible kinases (SIKs).
    Darling NJ; Cohen P
    Biochem J; 2021 Apr; 478(7):1377-1397. PubMed ID: 33861845
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Risk Stratification Using a Novel Genetic Classifier Including
    Jung CK; Jung SH; Jeon S; Jeong YM; Kim Y; Lee S; Bae JS; Chung YJ
    Thyroid; 2020 Nov; 30(11):1589-1600. PubMed ID: 32326836
    [No Abstract]    [Full Text] [Related]  

  • 11. Differences in Mutational Profile between Follicular Thyroid Carcinoma and Follicular Thyroid Adenoma Identified Using Next Generation Sequencing.
    Borowczyk M; Szczepanek-Parulska E; Dębicki S; Budny B; Verburg FA; Filipowicz D; Więckowska B; Janicka-Jedyńska M; Gil L; Ziemnicka K; Ruchała M
    Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31248021
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. An occult urothelial carcinoma with wide multiorgan metastases and its genetic alteration profiling: Case report and literature review.
    Bu K; Shi Z; Lu Y; Zhao J; Li B
    Medicine (Baltimore); 2019 Apr; 98(16):e15245. PubMed ID: 31008958
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. lkb1 deletion in periosteal mesenchymal progenitors induces osteogenic tumors through mTORC1 activation.
    Han Y; Feng H; Sun J; Liang X; Wang Z; Xing W; Dai Q; Yang Y; Han A; Wei Z; Bi Q; Ji H; Kang T; Zou W
    J Clin Invest; 2019 May; 129(5):1895-1909. PubMed ID: 30830877
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Possible hints and pitfalls in diagnosing Peutz-Jeghers syndrome.
    Renes JS; Knijnenburg J; Chitoe-Ramawadhdoebe S; Gille JJP; de Bruin C; Barge-Schaapveld DQCM
    J Pediatr Endocrinol Metab; 2018 Dec; 31(12):1381-1386. PubMed ID: 30447145
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Genetic mutation analysis of the malignant transformation of sinonasal inverted papilloma by targeted amplicon sequencing.
    Yasukawa S; Kano S; Hatakeyama H; Nakamaru Y; Takagi D; Mizumachi T; Suzuki M; Suzuki T; Nakazono A; Tanaka S; Nishihara H; Homma A
    Int J Clin Oncol; 2018 Oct; 23(5):835-843. PubMed ID: 29779136
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Novel Germline
    Lopez C; Abuel-Haija M; Pena L; Coppola D
    Cancer Genomics Proteomics; 2018; 15(2):115-120. PubMed ID: 29496690
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Calcium signalling links MYC to NUAK1.
    Monteverde T; Tait-Mulder J; Hedley A; Knight JR; Sansom OJ; Murphy DJ
    Oncogene; 2018 Feb; 37(8):982-992. PubMed ID: 29106388
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Neuroblastoma cells undergo transcriptomic alterations upon dissemination into the bone marrow and subsequent tumor progression.
    Rifatbegovic F; Frech C; Abbasi MR; Taschner-Mandl S; Weiss T; Schmidt WM; Schmidt I; Ladenstein R; Ambros IM; Ambros PF
    Int J Cancer; 2018 Jan; 142(2):297-307. PubMed ID: 28921546
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Clinical manifestations and stk11 germline mutations in Taiwanese patients with Peutz-Jeghers syndrome.
    Chiang JM; Chen TC
    Asian J Surg; 2018 Sep; 41(5):480-485. PubMed ID: 28869103
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. cancer Screening Recommendations and Clinical Management of Inherited Gastrointestinal cancer Syndromes in Childhood.
    Achatz MI; Porter CC; Brugières L; Druker H; Frebourg T; Foulkes WD; Kratz CP; Kuiper RP; Hansford JR; Hernandez HS; Nathanson KL; Kohlmann WK; Doros L; Onel K; Schneider KW; Scollon SR; Tabori U; Tomlinson GE; Evans DGR; Plon SE
    Clin Cancer Res; 2017 Jul; 23(13):e107-e114. PubMed ID: 28674119
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.